Richard T Kenney
CIK 1606653 · Chief Medical Officer · last filed 2025-12-04
Richard T Kenney is a Chief Medical Officer who has filed 12 SEC Form 4 insider transactions across 1 company since 2021. Across all open-market trades the lifetime net is +$38.6K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
12
$38.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Chief Medical Officer | 9,374 | $1.26 | $11.8K | $38.6K | 8 | 2025-08-21 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-04 | — | Mixed | −9,374 | $0 | |
| 2025-08-21 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-07-15 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +8,000 | $0 | EDGAR |
| 2024-12-05 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +1,271 | $0 | EDGAR |
| 2023-02-17 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Mixed | — | $0 | EDGAR |
| 2022-12-22 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +14,627 | $0 | EDGAR |
| 2021-06-09 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Buy (P) | +15,000 | $23.1K | EDGAR |
| 2021-05-20 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Buy (P) | +10,000 | $15.5K | EDGAR |
| 2021-04-01 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2016-01-06 | — | Grant (A) | +7,000 | $0 |